{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:37:29Z","timestamp":1787020649704,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"BMBF","award":["OnWEBDuals"],"award-info":[{"award-number":["OnWEBDuals"]}]},{"name":"DGM"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1135-3","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:07:44Z","timestamp":1522800464000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients"],"prefix":"10.1186","volume":"15","author":[{"given":"Caroline","family":"Perner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Perner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Stubendorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"F\u00f6rster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto W.","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian H.","family":"Heidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tino","family":"Prell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Grosskreutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,28]]},"reference":[{"issue":"46","key":"1135_CR1","doi-asserted-by":"publisher","first-page":"17913","DOI":"10.1073\/pnas.0804610105","volume":"105","author":"IM Chiu","year":"2008","unstructured":"Chiu IM, et al. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc Natl Acad Sci U S A. 2008;105(46):17913\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1135_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1468-1331.2008.02065.x","volume":"15","author":"T Holmoy","year":"2008","unstructured":"Holmoy T. T cells in amyotrophic lateral sclerosis. Eur J Neurol. 2008;15(4):360\u20136.","journal-title":"Eur J Neurol"},{"key":"1135_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12974-015-0350-4","volume":"12","author":"J Ehrhart","year":"2015","unstructured":"Ehrhart J, et al. Humoral factors in ALS patients during disease progression. J Neuroinflammation. 2015;12:127.","journal-title":"J Neuroinflammation"},{"issue":"6","key":"1135_CR4","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1001\/jamaneurol.2017.0357","volume":"74","author":"W Zhao","year":"2017","unstructured":"Zhao W, et al. Characterization of gene expression phenotype in amyotrophic lateral sclerosis monocytes. JAMA Neurol. 2017;74(6):677\u201385.","journal-title":"JAMA Neurol"},{"issue":"12","key":"1135_CR5","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/jamaneurol.2017.2255","volume":"74","author":"BJ Murdock","year":"2017","unstructured":"Murdock BJ, et al. Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression. JAMA Neurol. 2017;74(12):1446\u201354.","journal-title":"JAMA Neurol"},{"key":"1135_CR6","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3389\/fimmu.2017.01005","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Wang F. Role of neuroinflammation in amyotrophic lateral sclerosis: cellular mechanisms and therapeutic implications. Front Immunol. 2017;8:1005.","journal-title":"Front Immunol"},{"issue":"1","key":"1135_CR7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12974-016-0732-2","volume":"13","author":"G Nardo","year":"2016","unstructured":"Nardo G, et al. Immune response in peripheral axons delays disease progression in SOD1G93A mice. J Neuroinflammation. 2016;13(1):261.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1135_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrd.2015.10","volume":"15","author":"K Ley","year":"2016","unstructured":"Ley K, et al. Integrin-based therapeutics: biological basis, clinical use and new drugs. Nat Rev Drug Discov. 2016;15(3):173\u201383.","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"1135_CR9","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.nurt.2007.07.004","volume":"4","author":"C Savarin-Vuaillat","year":"2007","unstructured":"Savarin-Vuaillat C, Ransohoff RM. Chemokines and chemokine receptors in neurological disease: raise, retain, or reduce? Neurotherapeutics. 2007;4(4):590\u2013601.","journal-title":"Neurotherapeutics"},{"issue":"1-2","key":"1135_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2006.06.008","volume":"179","author":"R Zhang","year":"2006","unstructured":"Zhang R, et al. MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol. 2006;179(1-2):87\u201393.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"1135_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00401-016-1548-y","volume":"132","author":"L Zondler","year":"2016","unstructured":"Zondler L, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132(3):391\u2013411.","journal-title":"Acta Neuropathol"},{"issue":"40","key":"1135_CR12","doi-asserted-by":"publisher","first-page":"15558","DOI":"10.1073\/pnas.0807419105","volume":"105","author":"DR Beers","year":"2008","unstructured":"Beers DR, et al. CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc Natl Acad Sci U S A. 2008;105(40):15558\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"1135_CR13","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nm1555","volume":"13","author":"J El Khoury","year":"2007","unstructured":"El Khoury J, et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med. 2007;13(4):432\u20138.","journal-title":"Nat Med"},{"issue":"24","key":"1135_CR14","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1212\/WNL.0000000000004029","volume":"88","author":"K Poesen","year":"2017","unstructured":"Poesen K, et al. Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. Neurology. 2017;88(24):2302\u20139.","journal-title":"Neurology"},{"issue":"34","key":"1135_CR15","doi-asserted-by":"publisher","first-page":"9201","DOI":"10.1523\/JNEUROSCI.1470-07.2007","volume":"27","author":"L Ferraiuolo","year":"2007","unstructured":"Ferraiuolo L, et al. Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J Neurosci. 2007;27(34):9201\u201319.","journal-title":"J Neurosci"},{"issue":"1","key":"1135_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12974-016-0587-6","volume":"13","author":"I Rabinovich-Nikitin","year":"2016","unstructured":"Rabinovich-Nikitin I, et al. Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1(G93A) mice model of ALS. J Neuroinflammation. 2016;13(1):123.","journal-title":"J Neuroinflammation"},{"key":"1135_CR17","doi-asserted-by":"publisher","first-page":"4396368","DOI":"10.1155\/2016\/4396368","volume":"2016","author":"R Altara","year":"2016","unstructured":"Altara R, et al. The CXCL10\/CXCR3 axis and cardiac inflammation: implications for immunotherapy to treat infectious and noninfectious diseases of the heart. J Immunol Res. 2016;2016:4396368.","journal-title":"J Immunol Res"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1135-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-018-1135-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1135-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T20:04:52Z","timestamp":1553717092000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1135-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,28]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1135"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1135-3","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,28]]},"assertion":[{"value":"22 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All blood samples were collected with informed consent according to the Declaration of Helsinki with approval by the local ethics committee (EK 3633-12\/12).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"99"}}